BML (BMLKF) Other Stockholders Equity: $20.1 Mil (As of Mar. 2026)


BMLKF BML Inc BMLKF
73 GF Score
Price $25.21
GF Value $26.44
! 2 Warning Signs
View Full Analysis

What is BML Other Stockholders Equity?

BML BMLKF 73 Other Stockholders Equity is $20.1 Mil as of Mar. 2026. GuruFocus rates BMLKF with a GF Score™ of 73/100 and a GF Value™ of $26.44. The stock has 2 warning signs investors should review.

BML's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $20.1 Mil.

BML's quarterly Other Stockholders Equity declined from Sep. 2025 ($16.8 Mil) to Dec. 2025 ($15.7 Mil) but then increased from Dec. 2025 ($15.7 Mil) to Mar. 2026 ($20.1 Mil).

BML's annual Other Stockholders Equity increased from Mar. 2024 ($11.2 Mil) to Mar. 2025 ($16.0 Mil) and increased from Mar. 2025 ($16.0 Mil) to Mar. 2026 ($20.1 Mil).

BML Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for BML's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BML Other Stockholders Equity Chart

BML Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.31 2.40 11.16 16.00 20.08

BML Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.00 16.02 16.77 15.69 20.08
BMLKF
73GF Score
BML Inc BMLKF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BML Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $20.1 Mil mean?
BML (BMLKF) has a Other Stockholders Equity of $20.1 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on BML and its competitors.
Is BML's Other Stockholders Equity too high?
BML's current Other Stockholders Equity is $20.1 Mil. Overall, BML has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does BML's Other Stockholders Equity compare to TMO and DHR?
BML's Other Stockholders Equity of $20.1 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on BML and its competitors. BML's current Other Stockholders Equity is $20.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BML stock overvalued right now?
BML (BMLKF) has a current Other Stockholders Equity of $20.1 Mil. The stock's GF Value™ is $26.44, compared to a current price of $25.21 — trading 4.7% below its estimated fair value. The current Other Stockholders Equity is $20.1 Mil. BML's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For BML (BMLKF), the current Other Stockholders Equity is $20.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BML (BMLKF) Overvalued in 2026?

Based on GuruFocus' analysis, BML stock appears to be undervalued. The current stock price of $25.21 is trading 4.7% below its estimated GF Value™ of $26.44.

Key valuation signals for BMLKF:

  • Other Stockholders Equity: $20.1 Mil
  • GF Value™: $26.44 vs. price of $25.21 (4.7% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the BMLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BML Business Description

Other Exchanges 4694:Japan
Address 5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.
73GF Score

Get the complete analysis for BMLKF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.21
Price
$26.44
GF Value